AN OUTLOOK ON US BIOSIMILAR COMPETITION

|

article image
The pharmaceutical industry is experiencing change in ways it hasn’t ever before. On the demand side, we are seeing an aging population, increased prevalence of “Western” diseases, and a dramatic growth in global access to pharmaceuticals. On the supply side, we are seeing increased competition from emerging market players, and a shift in the way drugs are being developed, manufactured, and delivered. Meanwhile, policy makers are struggling with an inherent confl ict between desire to provide improved access to better medicines and the need to curb the growth of healthcare expenditures.

Spotlight

LI-COR Biosciences

At LI-COR Biosciences our mission is to help scientists find better answers to their questions. We believe that data of exceptional quality provides answers with exceptional clarity. In turn, the results help improve the world where we live and the quality of individual’s lives. More than 30,000 customers in more than 100 countries are using LI-COR research solutions on a daily basis. Their research includes cutting edge discovery in the areas of global climate change, drug discovery, environmental and life sciences. Our global team of employees understand that each day our goal is to impact lives. This is realized through a strength-based approach to team building that puts every employee on task to make a difference. Whether it's your first week or your 35th year, your skills and opinions are valued and must contribute to our mission to help improve the world where we live.

OTHER ARTICLES
MEDICAL

Better Purification and Recovery in Bioprocessing

Article | August 2, 2021

In the downstream portion of any bioprocess, one must pick through the dross before one can seize the gold the biotherapeutic that the bioprocess was always meant to generate. Unfortunately, the dross is both voluminous and various. And the biotherapeutic gold, unlike real gold, is corruptible. That is, it can suffer structural damage and activity loss. When discarding the dross and collecting the gold, bioprocessors must be efficient and gentle. They must, to the extent possible, eliminate contaminants and organic debris while ensuring that biotherapeutics avoid aggregation-inducing stresses and retain their integrity during purification and recovery. Anything less compromises purity and reduces yield. To purify and recover biotherapeutics efficiently and gently, bioprocessors must avail themselves of the most appropriate tools and techniques. Here, we talk with several experts about which tools and techniques can help bioprocessors overcome persistent challenges. Some of these experts also touch on new approaches that can help bioprocessors address emerging challenges.

Read More
DIAGNOSTICS

Making Predictions by Digitizing Bioprocessing

Article | April 20, 2021

With advances in data analytics and machine learning, the move from descriptive and diagnostic analytics to predictive and prescriptive analytics and controls—allowing us to better forecast and understand what will happen and thus optimize process outcomes—is not only feasible but inevitable, according to Bonnie Shum, principal engineer, pharma technical innovation, technology & manufacturing sciences and technology at Genentech. “Well-trained artificial intelligence systems can help drive better decision making and how data is analyzed from drug discovery to process development and to manufacturing processes,” she says. Those advances, though, only really matter when they improve the lives of patients. That’s exactly what Shum expects. “The convergence of digital transformation and operational/processing changes will be critical for the facilities of the future and meeting the needs of our patients,” she continues. “Digital solutions may one day provide fully automated bioprocessing, eliminating manual intervention and enabling us to anticipate potential process deviations to prevent process failures, leading to real-time release and thus faster access for patients.” To turn Bioprocessing 4.0 into a production line for precision healthcare, real-time release and quickly manufacturing personalized medicines will be critical. Adding digitization and advanced analytics wherever possible will drive those improvements. In fact, many of these improvements, especially moving from descriptive to predictive bioprocessing, depend on more digitization.

Read More

Spotlight

LI-COR Biosciences

At LI-COR Biosciences our mission is to help scientists find better answers to their questions. We believe that data of exceptional quality provides answers with exceptional clarity. In turn, the results help improve the world where we live and the quality of individual’s lives. More than 30,000 customers in more than 100 countries are using LI-COR research solutions on a daily basis. Their research includes cutting edge discovery in the areas of global climate change, drug discovery, environmental and life sciences. Our global team of employees understand that each day our goal is to impact lives. This is realized through a strength-based approach to team building that puts every employee on task to make a difference. Whether it's your first week or your 35th year, your skills and opinions are valued and must contribute to our mission to help improve the world where we live.

Events